WARNING! More information in the Privacy Policy and the use of cookies CHANGES IN BIOTON CORPORATE BODIES Warsaw, May 26, 2016 On May 25, 2016, the Supervisory Board of Bioton SA ("Bioton", "the Company") decided to appoint a strategy development committee whose main task is to introduce Bioton's operations to the global level and to develop the portfolio of diabetes products as the main area of the Company's operations. In connection with the above, the Supervisory Board decided to delegate its Chairman, Mr. Jubo Liu and Vice-Chairman, Mr. Dariusz Trzeciak, to exercise direct supervision over the development process and implementation of the new strategy of the Company. At the same time, the Supervisory Board of Bioton agreed with Mr. Sławomir Ziegert, President of Bioton, that he will take over the function at the Supervisory Board level and will serve with his extensive experience and specialist knowledge in the course of developing the global strategy of Bioton's operations. We highly appreciate the commitment and work of Mr. Ziegert and his contribution to the Company in the course of the restructuring and ownership changes. Bioton is a unique pharmaceutical company with enormous growth potential on international markets. This is the direction that we intend to develop dynamically. Under the leadership of Mr. Ziegert, since 2009 Bioton has transformed into a versatile company offering products for people with diabetes, including the flagship product - human insulin, and developing well-promising insulin analogues. Bioton's product base is solid and includes a unique portfolio of products for the treatment of diabetes. - said Jubo Liu, Chairman of the Supervisory Board of Bioton Mr. Ziegert's specialist knowledge and experience in managing a company offering products for people with diabetes, as well as a strategic approach, make him an excellent member of the Supervisory Board - said Jubo Liu. Therefore, with effect from 30 May 2016, Mr. Sławomir Ziegert will be replaced as the President of Bioton by Mr. Marcin Dukaczewski. Mr. Dukaczewski has been delegated to temporarily perform these tasks from the Supervisory Board and will manage the current affairs of the Company together with Mr. Adam Polonek, member of the management board of Bioton responsible for financial matters and Mr. Marek Dziki, member of the management board of Bioton responsible for commercialization. Ściśle współpracowałem z panem Dukaczewskim w ramach Rady Nadzorczej i jestem zdania, że jego bezpośrednie zaangażowanie i wkład jaki wniósł do Biotonu czyni go właściwą osobą do wdrożenia opracowywanej obecnie strategii Biotonu. Pan Dukaczewski jest związany z Biotonem od wielu lat i jako były Przewodniczący Rady Nadzorczej wniósł cenny wkład w proces restrukturyzacji Biotonu oraz przyczynił się do wejścia do Spółki nowych akcjonariuszy. – powiedział Jubo Liu. Głównym celem pana Dukaczewskiego jest przemodelowanie struktury Spółki oraz wdrożenie, wraz ze wzmocnionym zespołem zarządczym, nowej strategii Spółki przy pełnym wykorzystaniu efektu synergii ze strategicznymi akcjonariuszami Biotonu. It is worth emphasizing that the other minority shareholders represented in the Supervisory Board fully support the Supervisory Board taking active steps to develop and implement the new Bioton strategy. - said Dariusz Trzeciak, Vice Chairman of the Supervisory Board of Bioton. About company Mission of the company Authorities of BIOTON SA History of BIOTON SA Research and development Quality management Sales targets and global expansion Companies of the BIOTON SA Group Cooperation with the European Union Press office Privacy policy and the use of cookies contact AVAILABILITY OF GENSUPEN Press office Contact for media: Renata Ożarowska ozarowskar@bioton.pl Tel .: +22 721 40 02 Contact for investors: Renata Ożarowska ozarowskar@bioton.pl Tel .: +22 721 40 02 © 2016 BIOTON SA phone: +48 22 721 40 00 fax: +48 22 721 13 33 bioinfo@bioton.pl